Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

di Skinner, Heath D, Strom, Eric A, Motwani, Sabin B, Woodward, Wendy A, Green, Marjorie C, Babiera, Gildy, Booser, Daniel J, Meric-Bernstam, Funda, Buchholz, Thomas A
Pubblicazione 2013

Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

di Brewster, Abenaa M., Hortobagyi, Gabriel N., Broglio, Kristine R., Kau, Shu-Wan, Santa-Maria, Cesar A., Arun, Banu, Buzdar, Aman U., Booser, Daniel J., Valero, Vincente, Bondy, Melissa, Esteva, Francisco J.
Pubblicato in J Natl Cancer Inst (2008)

Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer

di Symmans, W. Fraser, Hatzis, Christos, Sotiriou, Christos, Andre, Fabrice, Peintinger, Florentia, Regitnig, Peter, Daxenbichler, Guenter, Desmedt, Christine, Domont, Julien, Marth, Christian, Delaloge, Suzette, Bauernhofer, Thomas, Valero, Vicente, Booser, Daniel J., Hortobagyi, Gabriel N., Pusztai, Lajos
Pubblicazione 2010

Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer

di Moulder, Stacy L., Symmans, W. Fraser, Booser, Daniel J., Madden, Timothy L., Lipsanen, Cindy, Yuan, Linda, Brewster, Abenaa M., Cristofanilli, Massimo, Hunt, Kelly K., Buchholz, Thomas A., Zwiebel, James, Valero, Vicente, Hortobagyi, Gabriel N., Esteva, Francisco J.
Pubblicato in Clin Cancer Res (2008)

Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy

di Morrow, Phuong K., Wulf, Gerburg M., Ensor, Joe, Booser, Daniel J., Moore, Julia A., Flores, Peter R., Xiong, Yan, Zhang, Siyuan, Krop, Ian E., Winer, Eric P., Kindelberger, David W., Coviello, Jeanna, Sahin, Aysegul A., Nuñez, Rodolfo, Hortobagyi, Gabriel N., Yu, Dihua, Esteva, Francisco J.
Pubblicazione 2011

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

di Santarpia, Libero, Qi, Yuan, Stemke-Hale, Katherine, Wang, Bailiang, Young, Elliana J., Booser, Daniel J., Holmes, Frankie A., O’Shaughnessy, Joyce, Hellerstedt, Beth, Pippen, John, Vidaurre, Tatiana, Gomez, Henry, Valero, Vicente, Hortobagyi, Gabriel N., Symmans, W. Fraser, Bottai, Giulia, Di Leo, Angelo, Gonzalez-Angulo, Ana M., Pusztai, Lajos
Pubblicazione 2012

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

di Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster, Abenaa M., Barcenas, Carlos H., Brown, Powel H., Giordano, Sharon H., Moulder, Stacy L., Booser, Daniel J., Moscow, Jeffrey A., Piekarz, Richard, Valero, Vicente, Ueno, Naoto T.
Pubblicato in Br J Cancer (2019)

GENOMIC PREDICTOR OF RESPONSE AND SURVIVAL FOLLOWING TAXANE-ANTHRACYCLINE CHEMOTHERAPY FOR INVASIVE BREAST CANCER

di Hatzis, Christos, Pusztai, Lajos, Valero, Vicente, Booser, Daniel J., Esserman, Laura, Lluch, Ana, Vidaurre, Tatiana, Holmes, Frankie, Souchon, Eduardo, Martin, Miguel, Cotrina, José, Gomez, Henry, Hubbard, Rebekah, Chacón, J. Ignacio, Ferrer-Lozano, Jaime, Dyer, Richard, Buxton, Meredith, Gong, Yun, Wu, Yun, Ibrahim, Nuhad, Andreopoulou, Eleni, Ueno, Naoto T., Hunt, Kelly, Yang, Wei, Nazario, Arlene, DeMichele, Angela, O’Shaughnessy, Joyce, Hortobagyi, Gabriel N., Symmans, W. Fraser
Pubblicato in JAMA (2011)